These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 24201751)

  • 21. Prognostic significance of C-reactive protein and smoking in patients with advanced non-small cell lung cancer treated with first-line palliative chemotherapy.
    Koch A; Fohlin H; Sörenson S
    J Thorac Oncol; 2009 Mar; 4(3):326-32. PubMed ID: 19155996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Implication of Pre-operative C-reactive Protein-Albumin Ratio as a Prognostic Factor of Patients With Pancreatic Ductal Adenocarcinoma: A Single-institutional Retrospective Study.
    Murakawa M; Yamamoto N; Kamioka Y; Kamiya M; Kobayashi S; Ueno M; Morimoto M; Atsumi Y; Aoyama T; Tamagawa H; Yukawa N; Rino Y; Masuda M; Morinaga S
    In Vivo; 2020; 34(1):347-353. PubMed ID: 31882498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic Value of the CRP/Alb Ratio, a Novel Inflammation-Based Score in Pancreatic Cancer.
    Liu Z; Jin K; Guo M; Long J; Liu L; Liu C; Xu J; Ni Q; Luo G; Yu X
    Ann Surg Oncol; 2017 Feb; 24(2):561-568. PubMed ID: 27650825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma levels of interleukin-33 and soluble suppression of tumorigenicity 2 in patients with advanced pancreatic ductal adenocarcinoma undergoing systemic chemotherapy.
    Kieler M; Unseld M; Wojta J; Kaider A; Bianconi D; Demyanets S; Prager GW
    Med Oncol; 2018 Nov; 36(1):1. PubMed ID: 30426271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intrahepatic cholangiocarcinoma prognostic determination using pre-operative serum C-reactive protein levels.
    Lin ZY; Liang ZX; Zhuang PL; Chen JW; Cao Y; Yan LX; Yun JP; Xie D; Cai MY
    BMC Cancer; 2016 Oct; 16(1):792. PubMed ID: 27733196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. External validation of the prognostic relevance of the advanced lung cancer inflammation index (ALI) in pancreatic cancer patients.
    Barth DA; Brenner C; Riedl JM; Prinz F; Klocker EV; Schlick K; Kornprat P; Lackner K; Stöger H; Stotz M; Gerger A; Pichler M
    Cancer Med; 2020 Aug; 9(15):5473-5479. PubMed ID: 32537935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas - a retrospective tumor marker prognostic study.
    Distler M; Pilarsky E; Kersting S; Grützmann R
    Int J Surg; 2013; 11(10):1067-72. PubMed ID: 24161419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a new outcome prediction model in carcinoma invading the bladder based on preoperative serum C-reactive protein and standard pathological risk factors: the TNR-C score.
    Gakis G; Todenhöfer T; Renninger M; Schilling D; Sievert KD; Schwentner C; Stenzl A
    BJU Int; 2011 Dec; 108(11):1800-5. PubMed ID: 21507193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The C-reactive protein/albumin ratio predicts overall survival of patients with advanced pancreatic cancer.
    Wu M; Guo J; Guo L; Zuo Q
    Tumour Biol; 2016 Sep; 37(9):12525-12533. PubMed ID: 27344157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Doublecortin and CaM kinase-like-1 as an independent prognostic factor in patients with resected pancreatic carcinoma.
    Nishio K; Kimura K; Amano R; Nakata B; Yamazoe S; Ohira G; Miura K; Kametani N; Tanaka H; Muguruma K; Hirakawa K; Ohira M
    World J Gastroenterol; 2017 Aug; 23(31):5764-5772. PubMed ID: 28883702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preoperative Platelet-to-Albumin Ratio Predicts Prognosis of Patients with Pancreatic Ductal Adenocarcinoma After Pancreatic Resection.
    Shirai Y; Shiba H; Haruki K; Horiuchi T; Saito N; Fujiwara Y; Sakamoto T; Uwagawa T; Yanaga K
    Anticancer Res; 2017 Feb; 37(2):787-793. PubMed ID: 28179331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet × CRP Multiplier Value as an Indicator of Poor Prognosis in Patients With Resectable Pancreatic Cancer.
    Miyamoto R; Oda T; Hashimoto S; Kurokawa T; Kohno K; Akashi Y; Ohara Y; Yamada K; Enomoto T; Ohkohchi N
    Pancreas; 2017 Jan; 46(1):35-41. PubMed ID: 27984485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Redefining the R1 resection for pancreatic ductal adenocarcinoma: tumour lymph nodal burden and lymph node ratio are the only prognostic factors associated with survival.
    John BJ; Naik P; Ironside A; Davidson BR; Fusai G; Gillmore R; Watkins J; Rahman SH
    HPB (Oxford); 2013 Sep; 15(9):674-80. PubMed ID: 23458477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Large platelet size is associated with poor outcome in patients with metastatic pancreatic cancer.
    Lembeck AL; Posch F; Klocker EV; Szkandera J; Schlick K; Stojakovic T; Kornprat P; Lackner C; Gerger A; Stoeger H; Stotz M; Pichler M
    Clin Chem Lab Med; 2019 Apr; 57(5):740-744. PubMed ID: 30307891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and Prognostic Significance of Coagulation Assays in Pancreatic Cancer Patients With Absence of Venous Thromboembolism.
    Sun W; Ren H; Gao CT; Ma WD; Luo L; Liu Y; Jin P; Hao JH
    Am J Clin Oncol; 2015 Dec; 38(6):550-6. PubMed ID: 24401666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Critical evaluation of the potential prognostic value of the pretreatment-derived neutrophil-lymphocyte ratio under consideration of C-reactive protein levels in clear cell renal cell carcinoma.
    Dalpiaz O; Luef T; Seles M; Stotz M; Stojakovic T; Pummer K; Zigeuner R; Hutterer GC; Pichler M
    Br J Cancer; 2017 Jan; 116(1):85-90. PubMed ID: 27907929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Matrix Metalloproteinase 8 Expression in a Tumour Predicts a Favourable Prognosis in Pancreatic Ductal Adenocarcinoma.
    Kaasinen M; Hagström J; Mustonen H; Sorsa T; Sund M; Haglund C; Seppänen H
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced mean platelet volume levels predict shorter survival in patients with resectable pancreatic ductal adenocarcinoma and type 2 diabetes.
    Yin JB; Li N; Cui MM; Wang X; Wang RT
    BMC Gastroenterol; 2020 May; 20(1):143. PubMed ID: 32393273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel inflammation-based prognostic score for patients with esophageal squamous cell carcinoma: the c-reactive protein/prognostic nutritional index ratio.
    Chen S; Yang X; Feng JF
    Oncotarget; 2016 Sep; 7(38):62123-62132. PubMed ID: 27557504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Implications of C-Reactive Protein as a Prognostic Marker in Advanced Cancer Patients in Palliative Care Settings.
    Amano K; Maeda I; Morita T; Miura T; Inoue S; Ikenaga M; Matsumoto Y; Baba M; Sekine R; Yamaguchi T; Hirohashi T; Tajima T; Tatara R; Watanabe H; Otani H; Takigawa C; Matsuda Y; Nagaoka H; Mori M; Kinoshita H
    J Pain Symptom Manage; 2016 May; 51(5):860-7. PubMed ID: 26826676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.